Tissue Regenix Group PLC
LSE:TRX
Income Statement
Earnings Waterfall
Tissue Regenix Group PLC
Income Statement
Tissue Regenix Group PLC
| Jul-2009 | Jan-2010 | Jul-2010 | Jan-2011 | Jul-2011 | Jan-2012 | Jul-2012 | Jan-2013 | Jul-2013 | Jan-2014 | Jul-2014 | Jan-2015 | Jul-2015 | Jan-2016 | Jul-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
+55%
|
0
N/A
|
0
-35%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-88%
|
0
+67%
|
0
+900%
|
0
+240%
|
1
+140%
|
1
+46%
|
2
+39%
|
2
+30%
|
6
+198%
|
9
+47%
|
14
+51%
|
12
-15%
|
16
+32%
|
16
+1%
|
16
-2%
|
21
+33%
|
20
-6%
|
32
+60%
|
24
-23%
|
27
+9%
|
26
-2%
|
27
+2%
|
29
+6%
|
26
-9%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(3)
|
(4)
|
(7)
|
(6)
|
(9)
|
(9)
|
(9)
|
(12)
|
(11)
|
(18)
|
(13)
|
(14)
|
(13)
|
(13)
|
(15)
|
(15)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
+39%
|
1
-11%
|
1
-4%
|
3
+305%
|
5
+61%
|
7
+41%
|
6
-22%
|
7
+31%
|
8
+2%
|
7
-4%
|
10
+31%
|
8
-11%
|
14
+64%
|
11
-19%
|
13
+13%
|
13
+2%
|
14
+8%
|
14
-3%
|
11
-21%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(7)
|
(8)
|
(8)
|
(9)
|
(11)
|
(13)
|
(14)
|
(12)
|
(15)
|
(14)
|
(17)
|
(14)
|
(16)
|
(14)
|
(12)
|
(15)
|
(13)
|
(19)
|
(13)
|
(14)
|
(14)
|
(14)
|
(13)
|
(11)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(1)
|
(1)
|
(3)
|
(2)
|
(4)
|
(2)
|
(5)
|
(3)
|
(8)
|
(5)
|
(9)
|
(7)
|
(13)
|
(10)
|
(12)
|
(12)
|
(14)
|
(14)
|
(14)
|
(13)
|
(14)
|
(11)
|
(15)
|
(13)
|
(19)
|
(13)
|
(14)
|
(14)
|
(14)
|
(13)
|
(11)
|
|
| Research & Development |
0
|
0
|
0
|
(1)
|
0
|
(1)
|
0
|
(2)
|
0
|
(3)
|
0
|
(3)
|
0
|
(4)
|
0
|
(4)
|
0
|
(2)
|
0
|
(2)
|
0
|
(2)
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
+48%
|
(1)
-485%
|
(2)
-155%
|
(3)
-35%
|
(3)
-14%
|
(4)
-24%
|
(4)
-19%
|
(5)
-10%
|
(7)
-35%
|
(8)
-21%
|
(8)
-5%
|
(9)
-4%
|
(10)
-18%
|
(12)
-14%
|
(13)
-11%
|
(11)
+15%
|
(12)
-6%
|
(9)
+27%
|
(10)
-18%
|
(8)
+19%
|
(9)
-7%
|
(7)
+24%
|
(5)
+24%
|
(5)
-3%
|
(4)
+22%
|
(5)
-31%
|
(2)
+63%
|
(1)
+52%
|
(1)
+36%
|
(0)
+91%
|
0
N/A
|
(1)
N/A
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
(2)
|
0
|
(4)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(1)
|
0
|
(0)
|
(0)
|
(7)
|
(9)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Pre-Tax Income |
(2)
N/A
|
(0)
+95%
|
(4)
-3 642%
|
(6)
-26%
|
(3)
+54%
|
(3)
-14%
|
(3)
-18%
|
(4)
-15%
|
(4)
-12%
|
(6)
-41%
|
(8)
-22%
|
(8)
-7%
|
(8)
-4%
|
(10)
-18%
|
(11)
-14%
|
(13)
-10%
|
(11)
+13%
|
(13)
-21%
|
(10)
+23%
|
(11)
-7%
|
(8)
+23%
|
(9)
-12%
|
(7)
+21%
|
(13)
-71%
|
(15)
-19%
|
(5)
+66%
|
(7)
-32%
|
(3)
+58%
|
(2)
+26%
|
(2)
+10%
|
(1)
+45%
|
(1)
+45%
|
(2)
-204%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Income from Continuing Operations |
(2)
|
(0)
|
(4)
|
(5)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(6)
|
(7)
|
(8)
|
(8)
|
(10)
|
(11)
|
(11)
|
(10)
|
(12)
|
(9)
|
(10)
|
(8)
|
(9)
|
(7)
|
(12)
|
(14)
|
(5)
|
(7)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Net Income (Common) |
(2)
N/A
|
(0)
+90%
|
(4)
-1 817%
|
(5)
-23%
|
(2)
+57%
|
(3)
-14%
|
(3)
-19%
|
(4)
-9%
|
(4)
-11%
|
(6)
-44%
|
(7)
-23%
|
(8)
-10%
|
(8)
-3%
|
(9)
-20%
|
(11)
-15%
|
(11)
-4%
|
(9)
+17%
|
(11)
-22%
|
(9)
+20%
|
(10)
-11%
|
(8)
+22%
|
(9)
-10%
|
(7)
+24%
|
(12)
-84%
|
(14)
-21%
|
(5)
+67%
|
(6)
-33%
|
(3)
+58%
|
(2)
+26%
|
(2)
+14%
|
(1)
+36%
|
(1)
+35%
|
(1)
-92%
|
|
| EPS (Diluted) |
-0.02
N/A
|
0
N/A
|
-0.02
N/A
|
-0.01
+50%
|
0
N/A
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.27
-2 600%
|
0
N/A
|
-0.07
N/A
|
-0.09
-29%
|
-0.04
+56%
|
-0.03
+25%
|
-0.03
N/A
|
-0.02
+33%
|
-0.01
+50%
|
-0.02
-100%
|
|